A surgical procedure aimed at treating Alzheimer's disease, which involves draining an abnormal build-up of proteins in the brain, is being tested in clinical trials in Hong Kong. This operation was previously pioneered in mainland China but was banned due to safety and effectiveness concerns. Researchers at The Chinese University of Hong Kong are now conducting trials under strict scientific controls, with early results showing significant improvements in patients' basic skills and cognitive function. AI
IMPACT Potential new treatment avenue for Alzheimer's disease, offering hope for improved patient outcomes and quality of life.
RANK_REASON Clinical trial for a novel surgical procedure for Alzheimer's disease. [lever_c_demoted from research: ic=1 ai=0.4]
- Alzheimer's disease
- China
- Dr Tor Chiu
- Hangzhou
- Hong Kong
- National Health Commission of the People's Republic of China
- The Chinese University of Hong Kong
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
